Your browser doesn't support javascript.
loading
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Díez-Fuertes, Francisco; Iglesias-Caballero, María; García-Pérez, Javier; Monzón, Sara; Jiménez, Pilar; Varona, Sarai; Cuesta, Isabel; Zaballos, Ángel; Jiménez, Mercedes; Checa, Laura; Pozo, Francisco; Pérez-Olmeda, Mayte; Thomson, Michael M; Alcamí, José; Casas, Inmaculada.
Affiliation
  • Díez-Fuertes F; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain frdiez@clinic.cat icasas@isciii.es.
  • Iglesias-Caballero M; IDIBAPS-Hospital Clinic de Barcelona, Barcelona, Spain.
  • García-Pérez J; Respiratory Virus and Influenza Unit, National Center of Microbiology, National Influenza Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Monzón S; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Jiménez P; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Varona S; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Cuesta I; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Zaballos Á; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Jiménez M; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Checa L; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Pozo F; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Pérez-Olmeda M; Respiratory Virus and Influenza Unit, National Center of Microbiology, National Influenza Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Thomson MM; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Alcamí J; HIV Biology and Variability Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
  • Casas I; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
J Virol ; 95(3)2021 01 13.
Article in En | MEDLINE | ID: mdl-33127745
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Founder Effect / SARS-CoV-2 / COVID-19 Type of study: Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Virol Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Founder Effect / SARS-CoV-2 / COVID-19 Type of study: Prevalence_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: J Virol Year: 2021 Document type: Article